Half-year report · Q2
4588.TEDINET S100WI59
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29m | 2025-01-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥31m | 2024-01-01 → 2024-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥31m | 2024-01-01 → 2024-06-30 | Standalone | Net sales |
| Operating income | −¥1.3bn | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | −¥793m | 2024-01-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | −¥1.3bn | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥1.7bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥753m | 2024-01-01 → 2024-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥1.3bn | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥753m | 2024-01-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | −¥1.3bn | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | −¥1.7bn | 2024-01-01 → 2024-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥755m | 2024-01-01 → 2024-06-30 | Standalone | Profit loss |
| Total assets | ¥1.9bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥3.2bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥1.9bn | at 2024-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥493m | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥447m | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥2.8bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.4bn | at 2024-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥872m | at 2024-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥1.0bn | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.0bn | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥5m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥5m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥42m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥686m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-52.85 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-77.17 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.96 | 2024-01-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.1% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 24,961,600 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,961,600 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 20,961,600 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 434
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayments of lease obligations fin cf | CurrentYTDDuration_NonConsolidatedMember | -5072000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration_NonConsolidatedMember | 638294000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Payments for issuance of common stock fin cf | Prior1YTDDuration_NonConsolidatedMember | -2466000 | JPY |
| Payments for issuance of common stock fin cf | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration_NonConsolidatedMember | 686458000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration_NonConsolidatedMember | 42153000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration_NonConsolidatedMember | 23573000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration_NonConsolidatedMember | -23217000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration_NonConsolidatedMember | -415305000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration_NonConsolidatedMember | -1023393000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 1287763000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2165918000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant_NonConsolidatedMember | 872457000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant_NonConsolidatedMember | 1142525000 | JPY |
| Directors compensations sga | Prior1YTDDuration_NonConsolidatedMember | 51291000 | JPY |
| Directors compensations sga | CurrentYTDDuration_NonConsolidatedMember | 50136000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration_NonConsolidatedMember | 100704000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration_NonConsolidatedMember | 97504000 | JPY |
| Research and development expenses sga | Prior1YTDDuration_NonConsolidatedMember | 523975000 | JPY |
| Research and development expenses sga | CurrentYTDDuration_NonConsolidatedMember | 1017169000 | JPY |
| Business consignment expenses sga | Prior1YTDDuration_NonConsolidatedMember | 48079000 | JPY |
| Business consignment expenses sga | CurrentYTDDuration_NonConsolidatedMember | 40483000 | JPY |
| License fee sga | Prior1YTDDuration_NonConsolidatedMember | 12616000 | JPY |
| License fee sga | CurrentYTDDuration_NonConsolidatedMember | 13278000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-08-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第22期中(自 2025年１月１日 至 2025年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)オンコリスバイオファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | Oncolys BioPharma Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 浦田 泰生 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目１番28号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-5472-1578(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理・財務部長 米尾 哲治 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目１番28号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-5472-1578(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経理・財務部長 米尾 哲治 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E30058 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45880 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)オンコリスバイオファーマ株式会社 | |
| Filer name in english | FilingDateInstant | Oncolys BioPharma Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |